Overview
Jeune syndrome, also known as asphyxiating thoracic dystrophy (ATD) or Jeune asphyxiating thoracic dystrophy, is a rare inherited skeletal disorder classified among the ciliopathies. It is characterized by a narrow, bell-shaped thorax with short ribs that severely restrict lung growth and breathing, which can be life-threatening in the neonatal and infantile periods. The condition was first described by Mathis Jeune in 1955 and belongs to the group of short-rib thoracic dysplasias. The hallmark feature is the constricted thoracic cage, which leads to respiratory insufficiency of variable severity. Many affected infants experience severe respiratory distress at birth, and respiratory failure is the leading cause of mortality in the neonatal period. Additional skeletal features include short limbs (particularly shortened long bones), a characteristic 'trident' appearance of the acetabular roof on pelvic X-ray (trident acetabulum), polydactyly (extra fingers or toes) in some cases, and short stature. Beyond the skeletal system, Jeune syndrome can affect multiple organs. Renal involvement, including progressive nephronophthisis-like kidney disease and cystic renal changes, is common and may lead to chronic kidney failure in childhood or later life. Hepatic complications such as biliary dysgenesis, hepatic fibrosis, and cholestasis can also occur. Retinal dystrophy (progressive vision loss) and pancreatic abnormalities have been reported in some patients. Jeune syndrome is caused by mutations in genes involved in intraflagellar transport and cilia function, including IFT80, DYNC2H1, WDR19, IFT140, IFT172, TTC21B, WDR34, WDR60, TCTEX1D2, and others. The clinical severity is highly variable, even within families. Treatment is primarily supportive. For severe thoracic constriction, surgical thoracic expansion procedures (such as lateral thoracic expansion or vertical expandable prosthetic titanium rib implantation) may be performed to improve respiratory function. Respiratory support, including mechanical ventilation, may be necessary in the neonatal period. Renal and hepatic complications are managed as they arise, and organ transplantation may be considered in cases of end-stage organ failure. With improved surgical techniques and supportive care, survival into adulthood is increasingly possible for patients who survive the critical neonatal respiratory period.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Jeune syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Jeune syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Jeune syndrome.
Community
No community posts yet. Be the first to share your experience with Jeune syndrome.
Start the conversation →Latest news about Jeune syndrome
No recent news articles for Jeune syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Jeune syndrome
What is Jeune syndrome?
Jeune syndrome, also known as asphyxiating thoracic dystrophy (ATD) or Jeune asphyxiating thoracic dystrophy, is a rare inherited skeletal disorder classified among the ciliopathies. It is characterized by a narrow, bell-shaped thorax with short ribs that severely restrict lung growth and breathing, which can be life-threatening in the neonatal and infantile periods. The condition was first described by Mathis Jeune in 1955 and belongs to the group of short-rib thoracic dysplasias. The hallmark feature is the constricted thoracic cage, which leads to respiratory insufficiency of variable seve
How is Jeune syndrome inherited?
Jeune syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Jeune syndrome typically begin?
Typical onset of Jeune syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Jeune syndrome?
16 specialists and care centers treating Jeune syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.